Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -141,202 | -122,526 | -89,620 | -51,321 | -38,049 |
| Depreciation Amortization | 1,678 | 996 | 316 | -628 | 146 |
| Accounts receivable | -100,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,765 | 3,307 | -860 | 2,153 | 1,897 |
| Other Working Capital | -88,041 | 2,964 | 6,966 | 2,968 | 4,062 |
| Other Operating Activity | 100,601 | -1,377 | 3,710 | 708 | -216 |
| Operating Cash Flow | $-222,199 | $-116,636 | $-79,488 | $-46,120 | $-32,160 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 83,161 | -357,619 | -266,175 | -61,953 | 19,065 |
| PPE Investments | -3,614 | -1,290 | -2,167 | -155 | -1,206 |
| Sale Of Investment | 10,249 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $89,796 | $-358,909 | $-268,342 | $-62,108 | $17,859 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 765,154 | 517,059 | 173,096 | 33 | 11 |
| Common Stock Repurchased | N/A | N/A | N/A | -6 | N/A |
| Other Financing Activity | -2,638 | -1,796 | 278,435 | 28,987 | 103,243 |
| Financing Cash Flow | $762,516 | $515,263 | $451,531 | $29,014 | $103,254 |
| Beginning Cash Position | 169,510 | 129,792 | 26,091 | 105,305 | 16,352 |
| End Cash Position | 799,623 | 169,510 | 129,792 | 26,091 | 105,305 |
| Net Cash Flow | $630,113 | $39,718 | $103,701 | $-79,214 | $88,953 |
| Free Cash Flow | |||||
| Operating Cash Flow | -222,199 | -116,636 | -79,488 | -46,120 | -32,160 |
| Capital Expenditure | -3,614 | -1,290 | -2,167 | -155 | -1,206 |
| Free Cash Flow | -225,813 | -117,926 | -81,655 | -46,275 | -33,366 |